Legal Representation
Attorney
Sheila Fox Morrison
USPTO Deadlines
Next Deadline
1631 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-26)
Due Date
December 26, 2029
Grace Period Ends
June 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
49 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 17, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Dec 17, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Dec 17, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jul 2, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jul 2, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jul 2, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Dec 26, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Dec 26, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Nov 23, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Nov 22, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Oct 26, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Oct 25, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Oct 24, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Oct 24, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Oct 24, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Oct 24, 2023 | IUAF | S | USE AMENDMENT FILED |
Oct 12, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Apr 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 20, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 19, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 19, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 21, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED |
Jul 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 11, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Jul 5, 2022 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Jun 21, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 21, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jun 21, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jun 21, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Jun 21, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jun 1, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 31, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
May 31, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Apr 1, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Apr 1, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
Apr 1, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Mar 25, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Jan 13, 2022 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Jan 13, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
Jan 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jan 3, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jan 3, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Nov 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 9, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical research and scientific research use; diagnostic reagents and preparations for medical research and scientific research; kits containing reagents and a protocol for use thereof for medical research and scientific purposes; agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, or biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics
First Use Anywhere:
Jun 1, 2021
First Use in Commerce:
Jun 1, 2021
Class 005
Reagents, assays, enzymes, nucleotides, and buffers for medical use; diagnostic agents, reagents, preparations, and substances for medical use; kits containing reagents and a printed instructional protocol manual for use thereof for medical purposes; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, or diagnostic preparations for medical genetic testing and medical diagnostic purposes; reagents, assays, enzymes, nucleotides, buffers, and diagnostic agents and preparations for medical purposes in the fields of nucleic acid sequencing, genotyping, diagnostics, metagenomics, genetic testing, and genetics
First Use Anywhere:
Jun 1, 2021
First Use in Commerce:
Jun 1, 2021
Class 009
Apparatus and instruments for medical research and scientific research in laboratories, namely, genetic sequencers; laboratory devices for detecting genetic sequences; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical research and scientific research apparatus and instruments for use in genetic analysis; apparatus for DNA and RNA testing for research purposes; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for DNA and RNA analysis; computer hardware; computer hardware for use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; data processing apparatus; scientific and research apparatus and instruments, namely, nucleic acid sequencers, arrays, scanners, electronic imaging devices and analyzers, testing sample collection equipment, sample quality control instruments, sequencing reagent cartridges and trays, and test sample preparation equipment, for laboratory use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; next-generation sequencing (NGS) bioinformatics data processor; downloadable computer software for scientific analysis of genetic sequences; embedded software sold as a component of genetic sequencing devices for scientific analysis of genetic sequences; downloadable computer software for storing, organizing, and creating a searchable library of genetic data for use in sequence detection, and disease detection and diagnosis; downloadable computer software for database management and for storage of electronic data; downloadable computer software for creating searchable databases of information and data; downloadable computer software for use in connection with databases in the field of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; downloadable computer software for use in connection with medical and scientific research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; downloadable computer software for use in connection with DNA sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in connection with nucleic acid sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in connection with genomic sequencing, screening, and analysis services for medical research purposes; downloadable computer software for use in connection with genetic analysis and reporting services for medical and scientific research purposes; downloadable computer software for use in connection with next-generation sequencing (NGS) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; downloadable computer software for compressing and decompressing genomic data files; downloadable computer software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records
First Use Anywhere:
20200000
First Use in Commerce:
20200000
Additional Information
Design Mark
The mark consists of the stylized letters UG.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ULTIMA GENOMICS
Classification
International Classes
001
005
009